These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 457852)

  • 1. Laboratory evaluation of amikacin susceptibility testing by the AutoBac I system.
    Boughton WH; Berman SJ; Boughton MT
    J Clin Microbiol; 1979 Mar; 9(3):397-8. PubMed ID: 457852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC; Wennersten C; Kunz LJ; Poitras JW
    Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study.
    Thornsberry C; Gavan TL; Sherris JC; Balows A; Matsen JM; Sabath LD; Schoenknecht F; Thrupp LD; Washington JA
    Antimicrob Agents Chemother; 1975 Apr; 7(4):466-80. PubMed ID: 1147582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of Pseudomonas aeruginosa-gentamicin discrepancies encountered in an Autobac I-disk diffusion comparison.
    Mayo JB; Kiehn TE; Wong B; Bernard EM; Armstrong D
    Antimicrob Agents Chemother; 1982 Mar; 21(3):412-5. PubMed ID: 6808909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory evaluation of an automated antimicrobial susceptibility system.
    Stubbs KG; Wicher K
    Am J Clin Pathol; 1977 Dec; 68(6):769-777. PubMed ID: 602916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1981 May; 13(5):1000-3. PubMed ID: 6787072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
    Lobuseva AN; Kuznetsova SM; Samoĭlova LN
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.
    Barry AL; Thornsberry C; Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1980 Oct; 18(4):616-21. PubMed ID: 7447420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.
    Washington JA; Yu PK; Gavan TL; Schoenknecht FD; Thornsberry C
    Antimicrob Agents Chemother; 1979 Mar; 15(3):400-7. PubMed ID: 464567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of gentamicin- and amikacin-resistant bacteria in sink drains.
    Perryman FA; Flournoy DJ
    J Clin Microbiol; 1980 Jul; 12(1):79-83. PubMed ID: 7419703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
    Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
    Kelly MT; Matsen JM
    Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.
    de Girolami PC; Maher LA; Booth MT; St George DM
    J Clin Microbiol; 1980 Oct; 12(4):546-9. PubMed ID: 6999021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Swenson JM; Silcox VA; Good RC
    J Clin Microbiol; 1982 Dec; 16(6):1003-6. PubMed ID: 6298271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I.
    Cleary TJ; Maurer D
    Antimicrob Agents Chemother; 1978 May; 13(5):837-41. PubMed ID: 248270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study.
    Thornsberry C; Anhalt JP; Washington JA; McCarthy LR; Schoenknecht FD; Sherris JC; Spencer HJ
    J Clin Microbiol; 1980 Sep; 12(3):375-90. PubMed ID: 6783678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of amikacin, a new aminoglycoside, against clinical bacterial isolates from children.
    Marks MI
    J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):246-51. PubMed ID: 1127131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.
    Buesing MA; Jorgensen JH
    Antimicrob Agents Chemother; 1984 Feb; 25(2):283-5. PubMed ID: 6538773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.
    Kabins SA; Nathan C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):786-7. PubMed ID: 727766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.